Biosimilars Market Research Reports & Industry Analysis

Biosimilars or biogenerics, are generic non-patented chemical and therapeutic equivalents of brand name biopharmaceutical drugs. Biopharmaceuticals are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies, and nucleic acids such as DNA or RNA. However, biogenerics are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Industry participants are struggling with what to call these hybrid forms of biologics that will be created by the generic companies.

The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.

Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.

...Show More ...Show Less


Biosimilars Industry Research & Market Reports

  • Infliximab-Biosimilars Insight, 2022

    ... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Infliximab Understanding ... Read More

  • Interferon - Biosimilar Insight, 2022

    ... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Interferon Understanding ... Read More

  • Trastuzumab-Biosimilars Insight, 2022

    ... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Trastuzumab Understanding ... Read More

  • Darbepoetin alfa– Biosimilar Insight, 2022

    ... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More

  • Pegfilgrastim– Biosimilar Insight, 2022

    ... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Pegfilgrastim Understanding ... Read More

  • Japan Biosimilars: Landscape Today, Outlook Tomorrow

    ... of biosimilar tool to curb healthcare cost Biosimilars uptake varies as per each opportunity, Remicade BS vs. Rituxan BS Two poles of the curve A few skipping NHI listing due to manufacturing issues associated with ... Read More

  • Biosimilar Market Trends 2019

    ... therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed ... Read More

  • Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics

    ... Biologics Summary The Global Biosimilar market by product is projected to grow at a compound annual growth rate (CAGR) of 45.22%. The market is driven mainly by a constrained payer environment and patent expiration of ... Read More

  • In Vitro Toxicology Market

    ... study aims to derive crucial insights that will benefit all the major stakeholders of the industry in developing strategic business plans based on these emerging trends. The report provides market size and growth trends for ... Read More

  • Pharmaceutical Market Research Bundle (Monoclonal Antibody Markets, CMOs, Bioprocessing Markets, Biosimilar Drug Markets)

    ... combination of 4 complete Kalorama Information reports, including the following: What's Trending in Monoclonal Antibodies Biopharmaceutical Contract Manufacturing Organization Markets Single-Use Upstream Bioprocessing Markets The World Market for Biosimilars The reports are separate PDFs, exactly ... Read More

  • Single Use Upstream Bioprocessing Markets (Bioreactors, Media Bags, Bioprocess Containers, Tubing and Connectors, Mixing Systems, Sensors and Probes)

    ... Probes) analyzes the current and potential world market for single use systems for upstream bioprocessing. This report generally reviews the nature and direction of research, as well as future markets. Market forecasts cover various segments ... Read More

  • Biosimilars: Global Market, Trends and Competitor Analysis

    ... a complete picture of the biosimilars market, including information on the world, United States, EU, Germany, France, UK, Italy Spain, rest of Europe, Russia, Japan, India, China, South Korea, Australia, Brazil, Mexico, Turkey, Iran, Canada ... Read More

11 12 13 14 15 16 next >

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings